Slight Increased Risk for Carditis After BNT162b2 Vaccine Administration

A case-control study found a slight increase in risk for carditis in patients who have received Pfizer-BioNTech’s BNT162b2 vaccine.

Related Keywords

Hong Kong ,Coronavac Sinovac ,Pfizer ,Department Of Health ,Hospital Authority Of Hong Kong ,Hospital Authority ,